We also previously demonstrated that simvastatin increases the apoptosis of colon cancer cells and suppresses ERK and Akt via the downregulation of IGF-1R expression and proapoptotic ERK activation and might be beneficial for the treatment of colon cancer. Here, AKT1 is linked to malignant colon neoplasm.